Julio Barredo is an Oncology physician affiliated with University of Miami. OpenAlex indexes 164 publications with 3,598 citations (h-index 27); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1150 NW 14th St
Suite 407
Miami, FL 331362137
Telephone
305-243-6837Registry record last updated 29 Jan 2013.
Clinical trials
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Boston Scientific CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2006–2008 per NIH RePORTER. The latest:
- Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
University of Miami School of Medicine
FY2008$297,398R01CA098152 - Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
University of Miami School of Medicine
FY2007$297,317R01CA098152 - Molecular Determinants of Methotrexate in ALL
University of Miami School of Medicine
FY2006$231,800R01CA098152
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Acute lymphoblastic leukemia mortality in Hispanic Americans
Leukemia & lymphoma/Leukemia and lymphoma
2020 - A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies
Pediatric Hematology and Oncology
2020 - Effect of a formal oncofertility program on fertility preservation rates—first year experience
Translational Andrology and Urology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”